Pharmacological assessment of Ru(II) complex with GidA protein- A novel topoisomerase II inhibitor towards cancer therapeutics-Reference-Cited by-同舟云学术

Pharmacological assessment of Ru(II) complex with GidA protein- A novel topoisomerase II inhibitor towards cancer therapeutics

Published:2022-05-05 Issue: Volume: Page:1-11
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Infanta. S Antony K Teresa¹²,Durairaju Nisshanthini¹,Raja Senthil³,Murugesan Thandeeswaran¹,Dhanapal Anand Raj⁴,Natarajan Karupannan³,Balakrishnan Ajithkumar⁵,Vedagiri Hemamalini⁵,Muthusamy Palaniswamy⁶,Jayaraman Angayarkanni¹

Affiliation:

1. Cancer Therapeutics Lab, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, Tamil Nadu, India

2. Department of Biotechnology, New Prince Shri Bhavani Arts and Science College, Chennai, Tamil Nadu, India

3. Department of Chemistry, Bharathiar University, Coimbatore, Tamil Nadu, India

4. Department of Biotechnology, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India

5. Molecular Genomics Laboratory, Department of Bioinformatics, Bharathiar University, Coimbatore, Tamil Nadu, India

6. Department of Microbiology, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India

Funder

Indian Council of Medical Research, New Delhi, India

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2022.2064332

Reference50 articles.

1. Photoactivated stereospecific cleavage of double-helical DNA by cobalt(III) complexes

2. Binding of Antitumor Ruthenium Complexes to DNA and Proteins: A Theoretical Approach

3. BIOVIA. (2019a). Dassault Systems, (Discovery Studio Visualizer

4. BIOVIA. (2019b). Dassault Systems, Release 2019; BIOVIA Pipeline Pilot, Release (2019).